title: ANCA-positive crescentic glomerulonephritis in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor alpha.
authors.affiliation: Nephrology Section, Internal Medicine Services Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Alkhunaizi
authors.affiliation: Division of Pathology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
authors.forename: Mohamad F
authors.initials: MF
authors.lastname: Dawamneh
mesh_terms: D000328:Adult; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001706:Biopsy; D057915:Drug Substitution; D000068800:Etanercept / Q000009:adverse effects*; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000187:drug effects* / Q000276:immunology / Q000648:ultrastructure; D008854:Microscopy, Electron; D009195:Peroxidase / Q000276:immunology*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D009195:Peroxidase; D000068800:Etanercept